Intellia Therapeutics (NTLA) Change in Receivables (2016 - 2026)
Intellia Therapeutics' Change in Receivables came in at -$1.81 million for Q2 2026, compared with $849,000 a year earlier.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Change in Receivables (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Intellia Therapeutics reported Change in Receivables of -$4.03 million; for FY2025, it was $951,000.
- Going back by year, Change in Receivables was -$27.94 million in FY2024, $32.69 million in FY2023, $1.74 million in FY2022 and -$99,000 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Change in Receivables since Q3 2024.
- Business Quant data shows NTLA's Change in Receivables at -$337,000 (Q1 2026), -$1.58 million (Q4 2025) and -$303,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Intellia Therapeutics | 1.69 Bn | 1.69 Bn | - | -1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.81 Mn |
| Mar 31, 2026 | -337,000.00 |
| Dec 31, 2025 | -1.58 Mn |
| Sep 30, 2025 | -303,000.00 |
| Jun 30, 2025 | 849,000.00 |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | -337,000.00 |
| Sep 30, 2024 | -3.47 Mn |
| Jun 30, 2024 | -24.10 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 29.97 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 151,000.00 |
| Mar 31, 2023 | 1.14 Mn |
| Dec 31, 2022 | -255,000.00 |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | -230,000.00 |
| Dec 31, 2021 | -460,000.00 |
| Sep 30, 2021 | 498,000.00 |
API Access
Intellia Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();